ACRS
Aclaris Therapeutics, Inc. · Healthcare
Director Andrew N Schiff sold $749K of Aclaris Therapeutics, Inc.
Sold$749,002
$16.45Price
45,539Shares
−7%Stake
What ACRS did after the filing
- The stock from Thu, Oct 6 close, $16.70
- +7.8%
- S&P 500, same days
- +5.6%
Measured over 30 trading days, to the Nov 17 close.
Traded Tue, Oct 4. Filed Thu, Oct 6, 1:58 PM ET, during the session. Returns use the Oct 6 close and the Nov 17 close. Not investment advice.